The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sanchez Ramiro since 2023.
This trader's CIK number is 1830326.
At the time of last reporting, Sanchez Ramiro was the Chief Medical Officer of Cerevel Therapeutics Holdings, Inc.. (stock ticker symbol CERE).
Also see all insider trading activities at Cerevel Therapeutics Holdings, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | CERE | 0 | $0 | 27,652 | $1,144,621 | 42,325 | $109,100 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-12-20 | CERE | Sale | 10,152 | 41.42 | 420,526 |
| 2023-12-19 | CERE | Option Ex | 24,825 | .00 | 0 |
| 2023-12-15 | CERE | Option Ex | 7,500 | 9.88 | 74,100 |
| 2023-12-15 | CERE | Sale | 7,500 | 41.39 | 310,395 |
| 2023-12-07 | CERE | Sale | 10,000 | 41.37 | 413,700 |
| 2023-12-07 | CERE | Option Ex | 10,000 | 3.50 | 35,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sanchez Ramiro (Chief Medical Officer of Cerevel Therapeutics Holdings, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.